Literature DB >> 4104974

Prophylactic lithium in affective disorders. Controlled trial.

A Coppen, R Noguera, J Bailey, B H Burns, M S Swani, E H Hare, R Gardner, R Maggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4104974     DOI： 10.1016/s0140-6736(71)91331-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

1.  Beta blockade in lithium tremor.

Authors:  J M Kellett; M Metcalfe; J Bailey; A J Coppen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

Review 2.  Continuation and maintenance therapy with antidepressive agents. An overview of research.

Authors:  A J Loonen; G J Zwanikken
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

3.  Lithium in pregnancy.

Authors:  M R Weinstein
Journal:  West J Med       Date:  1974-04

4.  Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).

Authors:  E H Bennie; A K Manzoor; A M Scott; G S Fell
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Clinical use of lithium in affective disorders.

Authors:  R R Fieve
Journal:  Drugs       Date:  1977-06       Impact factor: 9.546

Review 6.  Serum level monitoring and clinical pharmacokinetics of lithium.

Authors:  A Amdisen
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 7.  Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?

Authors:  Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Authors:  André R Brunoni; Laura Tadini; Felipe Fregni
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 9.  Lithium. Current status in psychiatric disorders.

Authors:  M Peet; J P Pratt
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

10.  The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.

Authors:  D G Grahame-Smith; A R Green
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.